lipid.site
Statin-intolerant, ASCVD secondary prevention

Evolocumab (Repatha)

Outcome

Stopped-cost

Would recommend

Mixed

Dose

140mg every 2 weeks

Payer

Private insurance

Coverage

Denied

Price

Not shared

Their story

After my heart attack I couldn't stay on statins because of muscle pain. My plan denied Repatha even with the paperwork from my cardiologist. I switched to Lerochol through the direct cash program while my appeal sat in limbo. The monthly shot has been easy.

Their story

  1. Atorvastatin · Apr 2024 to Jul 2024 · Stopped-side effects

  2. Evolocumab (Repatha) · Aug 2024 to Aug 2024 · Stopped-cost

  3. Lerodalcibep (Lerochol) · Jan 2026 to now · Well tolerated & effective

LDL (mg/dL)apoB (mg/dL)
1654812252
20252026
All lab values
DateTotal cholLDLNon-HDLHDLTrigLp(a)ApoB
2024-03-1524016519842160-122
2026-04-15120487644140-52

Topics:Statin intolerancePCSK9 denied

Comments

Share experiences and logistics (pharmacy, cost, coupons), not medical advice. For decisions about your treatment, talk to your clinician.

No comments yet.

Sign in to comment.